British Medical Journal (Abstracts)
2010-01-01
Drug for low sexual desire carries significant harms, FDA advisers find.
Ray Moynihan
Index: BMJ 341 , c3339, (2010)
Full Text: HTML
Abstract
Related Articles:
Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
2011-11-01
[J. Sex. Med. 8(11) , 3160-72, (2011)]
Open-label extension study of flibanserin in women with hypoactive sexual desire disorder.
2012-12-01
[J. Sex. Med. 9(12) , 3180-8, (2012)]
Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction.
2011-12-01
[J. Sex. Med. 8(12) , 3262-70, (2011)]
Population pharmacokinetic/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers.
2012-06-01
[Pharm. Res. 29(6) , 1518-29, (2012)]
Compte rendu du congrès 2013 de l’International Society for the Study of Women's Sexual Health (ISSWSH)
2013-05-01
[Gynecol. Obstet. Fertil. 41(5) , 330-3, (2013)]